Aryel Heitor Ferreira

PhD in Nuclear Technology - Materials from the Nuclear and Energy Research Institute (IPEN) - University of São Paulo (USP), specializing in Radiopharmacy. Bachelor's degree in Technological Chemistry from the Catholic University of Santos. Currently, he is a researcher at the Mackenzie Institute for Research in Graphene and Nanotechnologies (MackGraphe), Professor in the Graduate Program in Principles of Surgery at the Mackenzie Evangelical Medical School of Paraná (FEMPAR), and a Member of the Brazilian Society of Nuclear Biosciences (SBBN). He has worked as a Senior Consultant in market intelligence at The Graphene Council (USA). He has experience in research and innovation, as well as in technical-scientific feasibility analysis. His research focuses on nanomaterials for biomedical applications, the development of peptide-based radiopharmaceuticals and protein nanoparticles for cancer diagnosis and therapy, nanostructured systems for drug delivery, and nanostructured dressings with both diagnostic and therapeutic functions. He also has expertise in lyophilized kit formulations, radiolabeling of molecules with radioisotopes for PET/CT or SPECT/CT imaging, and in vitro and preclinical testing in various animal models. (Source: Lattes Curriculum)